Bethany A Rhoten1, Jessie I Sellers2, Breanna Baraff2, Kelly H Holler2, Sheila H Ridner2. 1. Vanderbilt University School of Nursing, 461 21st Avenue South 520 Godchaux Hall, Nashville, TN, 37240, USA. Bethany.rhoten@vanderbilt.edu. 2. Vanderbilt University School of Nursing, 461 21st Avenue South 520 Godchaux Hall, Nashville, TN, 37240, USA.
Abstract
PURPOSE: Patients with recurrent head and neck cancer (HNC) may feel overwhelmed at the prospect of having to consider treatment options particularly if they recently completed treatment for their primary disease or when they have no options that may lead to long-term survival. The purpose of this study was to examine patient priorities and preferences during treatment decision-making for recurrent HNC. METHODS: Individuals with newly diagnosed recurrent HNC were recruited at a National Cancer Institute-Designated Cancer Center. Participants were interviewed using a structured interview guide. Descriptive statistics were used to describe participants, and qualitative template analysis was used to analyze interview data. RESULTS: Participants (n = 38) considered information from healthcare providers, likelihood of treatment success, and other patient-specific factors in making their treatment decisions. CONCLUSIONS: Although patients with recurrent HNC endorse a myriad of decision-making factors, the recommendation of their healthcare provider and the likelihood of treatment success are of paramount importance. Future research should focus on methods to rapidly identify patient priorities at the time of diagnosed recurrence while respecting patient coping and communication styles.
PURPOSE: Patients with recurrent head and neck cancer (HNC) may feel overwhelmed at the prospect of having to consider treatment options particularly if they recently completed treatment for their primary disease or when they have no options that may lead to long-term survival. The purpose of this study was to examine patient priorities and preferences during treatment decision-making for recurrent HNC. METHODS: Individuals with newly diagnosed recurrent HNC were recruited at a National Cancer Institute-Designated Cancer Center. Participants were interviewed using a structured interview guide. Descriptive statistics were used to describe participants, and qualitative template analysis was used to analyze interview data. RESULTS: Participants (n = 38) considered information from healthcare providers, likelihood of treatment success, and other patient-specific factors in making their treatment decisions. CONCLUSIONS: Although patients with recurrent HNC endorse a myriad of decision-making factors, the recommendation of their healthcare provider and the likelihood of treatment success are of paramount importance. Future research should focus on methods to rapidly identify patient priorities at the time of diagnosed recurrence while respecting patient coping and communication styles.
Entities:
Keywords:
Decision-making; Head and neck cancer; Quality of life; Recurrence; Survivorship
Authors: B Brockstein; D J Haraf; A W Rademaker; M S Kies; K M Stenson; F Rosen; B B Mittal; H Pelzer; B B Fung; M-E Witt; B Wenig; L Portugal; R W Weichselbaum; E E Vokes Journal: Ann Oncol Date: 2004-08 Impact factor: 32.976
Authors: Ivan M G Agra; Andre L Carvalho; Everton Pontes; Olimpio D Campos; Fabio S Ulbrich; Jose Magrin; Luiz P Kowalski Journal: Arch Otolaryngol Head Neck Surg Date: 2003-12
Authors: Maria Cherba; Boris H J M Brummans; Michael P Hier; Lauriane Giguère; Gabrielle Chartier; Hannah Jacobs; Véronique-Isabelle Forest; Alex Mlynarek; Khalil Sultanem; Melissa Henry Journal: Curr Oncol Date: 2022-05-05 Impact factor: 3.109